FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to the pharmaceutical industry, in particular to the phillyrin/phillygenin composition in the preparation of a medicament or a medical product for the relief and/or treatment of influenza and pneumonia. Use of a phillyrin/phillygenin composition that includes phillyrin and phillygenin, wherein the mass ratio of phillyrin to phillygenin in the phillyrin/phillygenin composition is 80–98:2–20, when preparing a medicament or a medical product for the relief and/or treatment of influenza and pneumonia. Medicament or medical product for the relief and/or treatment of influenza and pneumonia comprising a phillyrin/phillygenin composition containing phillyrin and phillygenin, characterized in that the mass ratio of phillyrin to phillygenin in the phillyrin/phillygenin composition is 80–98:2–20.
EFFECT: above composition is effective for the relief and/or treatment of influenza and pneumonia.
7 cl, 22 tbl, 54 ex
| Title |
Year |
Author |
Number |
| PHYLLIGENIN AND IBUPROPHEN ETHER, METHOD OF ITS PRODUCTION AND ITS APPLICATION |
2014 |
- Fu, Li
- Fan, Hongyu
- Wang, Shuo
|
RU2659072C1 |
| FILLYGENIN AND GLUCURONIC ACID DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF |
2016 |
- Fu, Li
- Fan, Hongyu
- Jiang, Renwu
- Zhang, Yu
- Wang, Kaiqian
- Liu, Zhengxian
|
RU2684100C1 |
| METHODS FOR CHEMICAL SYNTHESIS OF PHYLLYRINE |
2014 |
|
RU2667917C2 |
| PHILLYRIN AND ITS DERIVATIVES FOR SUPPRESSION OF THE 3CLPRO PROTEIN AND FIGHTING THE COVID-19 VIRUS |
2021 |
- Yang, Zifeng
- Fu, Li
- Jiang, Ge
- Zhong, Nanshan
- Yang, Wei
- Ma, Qinhai
- Hui, Min
- Li, Chufang
- Wang, Shuo
- Pan, Weiyi
- Lu, Qi
- Song, Aiai
- Hou, Jirui
- Li, Runfeng
- Lu, Mingming
- Wang, Yingping
- Liu, Yang
- Liu, Guoyou
- Fu, Wenfei
- Feng, Xue
- Zhou, Qingfeng
- Yi, Xiaofeng
- Lin, Rongxin
- Zhang, Yu
|
RU2804307C1 |
| FORZICYASIDE SULFATE AND ITS DERIVATIVES, METHOD FOR ITS PRODUCTION AND ITS APPLICATION |
2014 |
|
RU2642784C2 |
| APPLICATION OF EXTRACTS OF GINSENG, GYNSENOSIDES AND DERIVATIVES OF GINSENOSIDE FOR THE PREPARATION OF MEDICAL PRODUCTS OR REMEDIES FOR THE TREATMENT OF DISORDERS CAUSED BY CMV |
2016 |
- Fu, Li
- Wang, Kaiqian
- Hui, Min
- Li, Fan
- Fan, Hongyu
- Wang, Shuo
|
RU2679903C1 |
| COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES, INCLUDING ANTITUMOR EFFECTS |
2021 |
- Wang, Shuo
- Fu, Li
- Liu, Yang
- Lu, Mingming
- Lin, Rongxin
- Fu, Wenfei
- Feng, Xue
|
RU2812611C1 |
| ANTIVIRAL COMPOUND OF MULTIPLE ACTION, ITS COMPOSITION AND METHOD OF TREATING VIRAL DISEASES |
2012 |
|
RU2597150C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL DISEASES |
2010 |
- Smirnov Vjacheslav Sergeevich
|
RU2438694C1 |
| COMPOSITION BASED ON MEDICINAL MATERIALS OF TRADITIONAL CHINESE MEDICINE FOR TREATMENT OF METABOLIC SYNDROME, ITS PRODUCTION METHOD AND USE, AND PHARMACEUTICAL DRUG BASED ON IT AND ITS USE |
2019 |
|
RU2780451C1 |
